Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus associated membranous glomerulonephritis

C Stehman-Breen1, C E Alpers, W G Couser

  • 1Division of Nephrology, University of Washington Medical Center, Seattle 98195, USA.

Clinical Nephrology
|September 1, 1995
PubMed
Summary

Hepatitis C virus (HCV) infection is linked to kidney disease. This study found four patients with membranous glomerulonephritis and HCV, who responded positively to alpha-interferon treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents.

Current medical research and opinion·2009
Same author

Tubular basement membrane immune deposits in association with BK polyomavirus nephropathy.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007
Same author

A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy.

Clinical nephrology·2006
Same author

An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis.

Journal of internal medicine·2006
Same author

PTPRQ is a novel phosphatidylinositol phosphatase that can be expressed as a cytoplasmic protein or as a subcellularly localized receptor-like protein.

Experimental cell research·2003

Area of Science:

  • Nephrology
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is a global health concern associated with numerous extrahepatic manifestations.
  • Glomerular diseases, particularly membranous glomerulonephritis (MGN), are increasingly recognized as potential complications of HCV infection.

Observation:

  • This report details four patients presenting with MGN and concurrent HCV infection.
  • These patients exhibited distinct clinical and serological profiles compared to those with HCV-associated membranoproliferative glomerulonephritis, notably normal complement levels and absence of rheumatoid factor or cryoglobulinemia.

Findings:

  • Liver biopsy in one patient indicated chronic active hepatitis, despite minimally elevated liver enzymes and normal coagulation profiles.
  • Three patients treated with alpha-interferon demonstrated improvement in proteinuria and liver function, suggesting a beneficial role for interferon therapy.

Related Experiment Videos

Implications:

  • Alpha-interferon may effectively manage proteinuria and improve liver function in HCV-infected patients with MGN, potentially by suppressing viral load.
  • Further research, including randomized controlled trials, is crucial to elucidate the virus's role in glomerular pathology and optimize alpha-interferon treatment strategies for HCV-related kidney disease.